KOVESDY, CSABA P.
B222 COLEMAN COLLEGE OF MEDICINE BUILDING
956 COURT AVENUE
MEMPHIS TN 381632116
Dr. Kovesdy’s research interests are centered on epidemiology and outcomes, cardiovascular risk factors, metabolic abnormalities, race-ethnicity, and bone and mineral disorders in pre-dialysis chronic kidney disease. He is Principal Investigator on several studies and federal grants in these areas. He has published his research in over 200 peer-reviewed articles, as well as numerous abstracts and book chapters.
Chronic kidney disease
Progression of CKD
Cardiovascular risk factors
Outcomes in patients with non-dialysis dependent CKD
- Lu JL, Kalantar-Zadeh K, Ma JZ, Quarles LD, Kovesdy CP. Association of Body Mass Index with Outcomes in Patients with CKD. J Am Soc Nephrol, 2014.
- Molnar MZ, Kalantar-Zadeh K, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Quarles DL, Kovesdy CP. Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol, 7 (63), 650-658, 2014.
- Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ. Observational Modeling of Strict vs. Conventional Blood Pressure Control in Patients with Chronic Kidney Disease. JAMA Int Med, 2014.
- Kovesdy, CP, Quarles, LD, Lott, EH, Lu, JL, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Survival advantage in black versus white men with CKD: effect of estimated GFR and case mix. Am J Kidney Dis, 62 (2), 228-35, 2013.
- Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol, 61 (15), 1626-33, 2013.
- Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med, 4 (159), 233-42, 2013.
- Kovesdy, CP, Lott, EH, Lu, JL, Malakauskas, SM, Ma, JZ, Molnar, MZ, Kalantar-Zadeh, K. Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation, 125 (5), 677-84, 2012.
- Kovesdy, CP, Lu, JL, Malakauskas, SM, Andress, DL, Kalantar-Zadeh, K, Ahmadzadeh, S. Paricalcitol versus ergocalciferol for secondary hyperparathyroidism in CKD stages 3 and 4: a randomized controlled trial. Am J Kidney Dis, 59 (1), 58-66, 2012.
- Kovesdy CP, Czira ME, Rudas A, Ujszaszi A, Rosivall L, Novak M, Kalantar-Zadeh K, Molnar MZ, Mucsi I. Body Mass Index, Waist Circumference and Mortality in Kidney Transplant Recipients. Am J Transplant, 12 (10), 2644-51, 2010.
- Kovesdy CP, George SM, Anderson JA, Kalantar-Zadeh K. Outcome-predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr, 2 (90), 407-14, 2009.